Legacy Giving

Imagine: a future when men no longer suffer or die from the most common cancer in Canadian men - prostate cancer.

By leaving a gift in your will, you can continue to help shape a brighter tomorrow for our sons and their loved ones after you're gone.

Your legacy of giving will carry on as future generations of Canadian men lead fuller, healthier, and happier lives than ever before.

What will your legacy be?

Benefits of leaving a gift in your will

Gifts in a will are, by far, the most popular type of legacy gift. Also known as bequests, gifts in a will are popular for the following reasons:
  • You will help support Canadian men living with prostate cancer without touching the assets and funds you need now.
  • You can change your mind at any time and amend or revoke the gift.
  • It reduces the taxes payable on your estate as your estate will receive a charitable tax receipt for the gift.

How do I leave a gift in my will?

Creating your legacy gift is as easy as 1,2,3!
  1. Make an appoitment with your lawyer.
  2. Create a new will or amend an existing will to reflect your wishes.
  3. Contact Prostate Cancer Canada so that we may thank you for your gift.

For any questions or concerns, please contact...

Maria Glidden
Coordinator, Donor Relations and Stewardship
(416) 441-2131 ext. 277

Help us take the first steps toward prevention. Donate Now

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.

Click here for news archive